Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.
23.05.2025 15:13:12

Medical Experts Urge FDA To Adopt New Policies To Prohibit Talc Use In Consumer Products

(RTTNews) - Friday, a panel of medical experts convened by the U.S. Food & Drug Administration discussed about the association between talc use and ovarian cancer, urging the agency to study and adopt new standards to prohibit the use of talc in consumer products such as gum, candy, rice and pharmaceuticals.

This comes as the experts stated that talc is carcinogenic, based on findings of numerous studies conducted over 30 years. These findings had forced Johnson & Johnson (JNJ) to remove the company's body powders from the market in recent years.

Dr. George Tidmarsh, a pediatric neonatologist and professor at Stanford University. "In my opinion, it's not a matter of if talc should be removed from the U.S. market, it's a matter of how and when. It's a dangerous substance."

Notably, Dr. Daniel Cramer of Brigham and Women's Hospital and Harvard Medical School, was the first to publish a peer-reviewed study in 1982, revealing an increased ovarian cancer risk of atleast 82 percent in women who use talc-based powders for feminine hygiene.

Since then, over 40 studies have supported those findings in addition to tests conducted by FDA, which found presence of asbestos in cosmetic talc.

The concerns heightened last year when the National Institutes of Health affirmed "compelling evidence that genital talc use is associated with an increased risk of ovarian cancer."

Meanwhile, the Ovarian Cancer Association Consortium, consisting of top researchers from leading cancer research hospitals around the world, in 2022 called the genital exposure to talcum powder a "well established ovarian cancer risk factor." A similar stance was taken by the National Academy of Medicine.

"It was encouraging to see this distinguished panel with representatives from the FDA, NIH and the nation's leading hospitals and medical schools agree that there remains little doubt about the causal link between talc and cancer," said Andy Birchfield of the Beasley Allen Law Firm.

"In recent years, the science showing the dangers of talc exposure to women has only increased, with no new studies to indicate otherwise, and we look forward to presenting that evidence in court at the earliest possible opportunity."

Analysen zu Johnson & Johnson

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Donnerstag um 18 Uhr live: Maximale Rendite bei minimalem Risiko - durch Prop Trading Vermögen aufbauen

Am Donnerstagabend zeigt Dir Trading-Experte Thomas Hartmann, wie Du mit Fremdkapital sicher und strategisch ein Vermögen aufbauen kannst. Du bekommst exklusive Einblicke in reale Trading-Ergebnisse und erfährst Schritt für Schritt, wie diese zustande kamen.

Kostenfrei anmelden und dabei sein!

3 neue Aktien 📈 im BX Musterportfolio: Intuit, Deutsche Boerse & Euronext mit François Bloch

Im BX Morningcall werden folgende Aktien analysiert und erklärt – heute mit dem monatlichen Rebalancing:
NEU✅ Talanx
NEU✅ ANEA
NEU✅ Commerzbank

inklusive Rebalancing:
❌ TransDigm
❌ FISERV
❌ Motorola Solutions

👉🏽 https://bxplus.ch/bx-musterportfolio/

3 neue Aktien 📈 im BX Musterportfolio: Talanx, AENA & Commerzbank mit François Bloch

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’810.18 19.89 ISSMNU
Short 13’089.74 13.78 B1LSOU
Short 13’576.37 8.90 B6CSKU
SMI-Kurs: 12’298.50 04.06.2025 17:31:06
Long 11’785.02 18.68 BNAS9U
Long 11’545.04 13.70 B1FSHU
Long 11’068.75 9.00 BMYSUU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

finanzen.net News

Datum Titel
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
{{ARTIKEL.NEWS.BODY.TITEL}}